In Vitro Maturation for Polycystic Ovary Syndrome

In Vitro Maturation for Polycystic Ovary Syndrome
Study Type: Interventional
Age/Gender Requirements: 18-34 years (female)
Sponsor: University Reproductive Associates
Purpose: Researchers will assess “the efficacy and safety of In-Vitro Maturation (IVM) for women with Polycystic Ovarian Syndrome (PCOS).” The primary outcome measure will be the “incidence of biochemical pregnancy (definded as a rising Beta-HCG level),” but researchers will also be looking at the “number of immature oocytes retrieved…rates of maturation and fertilization…incidence of Ovarian Hyperstimulation Syndrome…[and] live births.”
http://hcp.lv/f1tVff